These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2650453)

  • 1. Studies on chromosome aberrations of peripheral T lymphocytes in cadaveric kidney allograft recipients.
    Ding Z
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3205-8. PubMed ID: 2650453
    [No Abstract]   [Full Text] [Related]  

  • 2. Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy.
    Lundgren G; Fehrman I; Gunnarsson R; Lindholm B; Tillegård A; Ost L; Groth CG
    Transplant Proc; 1982 Sep; 14(3):601-4. PubMed ID: 6758244
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracorporeal irradiation of the blood. Histological examinations of homografts in patients undergoing immunosuppressive therapy with ECIB before kidney transplantation.
    Weeke E; Henriksen B
    Acta Pathol Microbiol Scand A; 1974 May; 82(3):389-96. PubMed ID: 4604467
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial with AHLG Behring: lack of effect on cadaveric renal graft survival.
    Jakobsen A; Flatmark A; Lundgren G; Solheim B; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():205-12. PubMed ID: 6755682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
    Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
    Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
    [No Abstract]   [Full Text] [Related]  

  • 6. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rabbit anti-human thymocyte globulin in cadaver kidney transplantation. Preliminary experiences.
    Groth CG; Lundgren G; Ringdén O; Berg B; Grimfors G; Bieber CP
    Scand J Urol Nephrol Suppl; 1981; 64():200-4. PubMed ID: 6755681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 10. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 11. The state of the art in renal replacement programmes for chronic uraemia at the University of Rome.
    Cortesini R; Berloco P; Famulari A; Pretagostini R; Rossi M; Alfani D
    Life Support Syst; 1985; 3(2):110-4. PubMed ID: 3894812
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.
    Waer M; Vanrenterghem Y; Ang KK; Van der Schueren E; Michielsen P; Vandeputte M
    J Immunol; 1984 Feb; 132(2):1041-8. PubMed ID: 6228588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that perioperative portal venous inoculation with ultraviolet-B irradiated donor spleen cells sensitizes the recipients in cadaveric kidney transplantation.
    Sakagami K; Saito S; Fujiwara T; Uda M; Matsuno T; Orita K
    Transplant Proc; 1994 Aug; 26(4):2048-53. PubMed ID: 8066667
    [No Abstract]   [Full Text] [Related]  

  • 18. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.
    Simmons RL; Canafax DM; Fryd DS; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):76-81. PubMed ID: 3008390
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases.
    Lietz K; Lewandowski Z; Lao M; Paczek L; Gaciong Z
    Transpl Int; 2004 Feb; 17(2):78-88. PubMed ID: 14605803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.